VetSurgeon is sad to report that Sam Duff, a much loved figure in the profession, died last weekend.
Sam qualified from Edinburgh in 1970, and was a partner in mixed practice in Fife until 2002. More recently, he was a director of Equitique Ltd, an equine reproduction referral practice.
Sam was an active member of BVA Council, and its Member Services Group. He served on SPVS Council from 1993-2002, and was re-elected in 2003. He had recently been elected as Secretary of the Scottish branch of the BVA.
A memorial service will be held at 2.30pm on Thursday 9th July in Younger Hall, St Andrews.
According to the company, a similar percentage of respondents believe that senior cats would benefit clinically if they monitored blood pressure routinely in their senior years, and nearly 85% said that anti-hypertensive medication would increase the quality of life for their patients.
Time constraints were cited as the main barrier to routinely measuring blood pressure, but all of those questioned would be happy for a trained RVN to measure blood pressure in cats.
Ceva highlights studies which show show that hypertension affects one in eight cats over nine years old3, with the risk increasing as cats age or if they have other conditions such as chronic kidney disease (where one in three cats suffer with hypertension) or overactive thyroid disease (where an estimated one in four cats suffer with hypertension)4, 5, 6.
Rosanne Jepson, specialist in small animal internal medicine at the Royal Veterinary College said: "High blood pressure can cause severe damage to key body organs including the eyes, kidneys, heart and brain. Unfortunately, it is a condition that develops insidiously without early warning signs for the cat owner; a cat may seem perfectly fine until either the blood pressure is checked, or serious consequences of hypertension suddenly occur."
With this in mind, Ceva says it will host the first Feline Hypertension Month this May, to raise awareness of hypertension and improve the detection and management of high blood pressure in cats.
The company is also encouraging practices to take part in the 'Mercury Challenge', a study it is launching in the summer which will, it says, be the largest-ever European study into feline hypertension.
For information on feline hypertension, Feline Hypertension Month or the Mercury Challenge, contact your local Ceva Animal Health account manager.
References
Willows, the Solihull-based multidisciplinary referral centre, has announced that it has acquired The Veterinary Cardiorespiratory Centre, the renowned referral service run by Mike Martin MRCVS, RCVS Specialist in Veterinary Cardiology (pictured right).
Mike, together with Chris Linney and their team will shortly be moving half-an-hour up the road to join the team at Willows.
The company says that the move will offer a number of benefits to referring practitioners. Chief amongst these is the speed with which an accurate diagnosis can be made and treatment given, both as a result of having RCVS Specialists in neurology, imaging, medicine, soft tissue surgery (and now cardiology) under one roof and because of the state-of-the-art equipment at their disposal, including CT, MRI and digital fluoroscopy.
Lynne Hill, CEO, Willows Group said: ”I’m thrilled that Mike, Chris and their team are joining us at Willows. I have always held Mike in the highest regard and this is a tremendous opportunity for the practice to provide a truly collaborative ‘one-stop-shop’ for both clients and referring veterinary practices”.
Mike said: “I’m really looking forward to working at Willows Referral Service and being part of a multidisciplinary team. It's a logical move to provide Willows with the missing discipline of cardiology and I'm delighted Lynne Hill has allowed us to fulfil that role. There has been an increasing number of referrals between the two centres due to the complexity of cases - now that will be all under one roof and we can manage these much more effectively and offer the best service to our clients and their patients.”
For more information, visit www.willows.uk.net
All members of the practice team are invited to nominate their receptionist, as are members of the public. Nominations should highlight the dedication and effort the nominee demonstrates, and entries need to be in by the 31st January 2019.
BVRA founder Brian Faulkner MRCVS said: "Veterinary receptionists are as crucial to the success of a veterinary practice as any other role. They are first and last impression a client has of a veterinary practice and the association is keen to recognise and reward their unique contribution to the industry.
We’ve been astounded by how popular the BVRA has been since its launch one year ago with receptionists at every level of experience, reporting appreciation as well as the benefits of Accredited Veterinary Receptionist Award. It’s entirely appropriate that BVRA champions ‘best practice’ and therefore the BVRA’s Veterinary Receptionist of the Year Award will recognise their hard work."
Brian added: "We’re so grateful to all of our corporate sponsors in helping us get BVRA off the ground and grow. We are especially grateful to Feliway and Adaptil, sponsors of The Veterinary Receptionist of the Year Award. A motivated and inspired veterinary receptionist can be the difference between whether a client registers with your practice or not. So why not log onto the www.bvra.co.uk right now and nominate that receptionist who deserves to be acknowledged and celebrated?"
Three finalists will be chosen and invited to attend BVRA’s 2nd Annual congress on 16th March 2019 in Sutton Coldfield, where the winner will be announced.
To nominate your receptionist, visit: https://www.bvra.co.uk/Home/CPD.
Tracey, who started working in practice as a trainee in 1986 and qualified in 1989, spent her nursing career in both mixed and small animal practice in her home town of Hinckley, Leicestershire before retiring in 2018.
She says the book is mainly aimed at people thinking of embarking on a career as a veterinary nurse, but she also hopes colleagues in the profession will enjoy it, particularly those who are newer to the profession and have an interest in how things have progressed over the last three decades.
Tracey said: "Having enjoyed a very long career as a veterinary nurse, I wanted to take the opportunity to share some of my experiences, the happy, the sad and the sometimes downright crazy!
"The role of the veterinary nurse has changed so much over the last thirty years and continues to evolve with each passing year. My story is a light-hearted journey from my early years as a fresh-faced trainee to a fully qualified head nurse, will all the highs and lows along the way.
"The book will hopefully appeal to all members of the veterinary profession, past, present and future as well as to animal lovers everywhere. It was written from the heart to celebrate the work that veterinary nurses do, the diversity of their role and the steep learning curves that many of us had to climb."
You can read a sample of the book here.
Confessions of a veterinary nurse is available from all good bookstores, and Amazon, priced at £10.99.
Tramvetol is presented in two pack sizes of 30 and 100 tablets to assist practices with dispensing and storage as a Schedule 3 controlled drug. The meat flavoured 50mg tablets can also be divided into two equal parts to ensure accurate dosing.
Virbac says Tramvetol is suitable for both short courses and long-term treatment; 2-4mg per kg of Tramvetol can be administered every 8 hours or from 6 hours, if required, based on the intensity of the pain. In addition, Tramvetol has a wide therapeutic window and a maximum daily dose of 16mg per kg.
Commonly used in combination with other forms of analgesia, including NSAIDs1, Tramvetol is quickly absorbed and boats a rapid onset of action2. Peak plasma concentrations are achieved within 45 minutes3.
Dan Johnson, Product Manager at Virbac said: ‘Tramadol is already an important part of the analgesia toolkit for many veterinary practices. We hope that Tramvetol will prove to be a much more convenient option for practices, whilst helping to provide dogs with a better quality, pain free life’.
For more information, contact your Virbac Territory Manager.
Carprodyl Quadri is a pork-flavoured, four-way break tablet, available in two presentations of 50mg and 120mg. Each tablet offers four dosage strengths, designed to help you prescribe more accurately for a dog’s weight with fewer boxes on the shelves.
Part tablets can be kept in the blister pack for up to 72 hours, so clients can take home the exact amount of carprofen they require, thereby reducing cost and waste.
To support the launch of Carprodyl Quadri, Ceva is launching a range of marketing materials for veterinary practices. They include: dosage charts, dispensing envelopes, remember to order stickers to stick on boxes left on the shelves, reminder cards about the change for reception and dispensaries and client letters explaining why their prescription has changed.
Lucy Vernon, product manager at Ceva Animal Health said: "Carprodyl Quadri is an easy to administer carprofen that provides accurate dosing while reducing cost and waste and is a welcome addition to our popular pain management portfolio."
For further information, contact your local Ceva Animal Health territory manager.
The company says it has redesigned the packaging to make it more distinctive, the idea being that it makes stock control in the practice and vaccine management on the farm easier and it also makes it easier for veterinary surgeons to identify and grab the right product off the shelf.
The new, bright red packaging for Bovilis IBR Marker Live is shown right. What do you think? Comment below.
Hill's Pet Nutrition has announced that it will not be exhibiting at the British Small Animal Veterinary Association Congress this year, and instead will be found in a restaurant round the corner called The Strada.
The press release containing this news fluttered in at almost exactly same time as one from the BSAVA, in which President Grant Petrie revealed that Congress already has a record-breaking exhibition.
Hill's' spin on the story is that it's all part of a new way of thinking about how the company does business. Blake Hawley, DVM and Managing Director at Hill's Pet Nutrition said: "It's easy to fall into the same old habits and routines. In fact, it can be enormously comforting to predict that in the year ahead, one will deliver, and probably receive, expected results. We don't think that's really quite good enough. So, we made the difficult and very conscious decision to question what we do and challenge how we think about the way we do business."
Hill's goes on to say that it will continue to support BSAVA and help provide a great experience for people attending the Congress, by offering free Italian food, coffee or a glass of beer or wine from its new restaurant location.
Some might call that supportive of BSAVA. Others, less generous, might call it a way of benefitting from all the work that the BSAVA does to bring everyone together at Congress without contributing towards the costs.
Thankfully, though, it doesn't look like BSAVA has been hit that hard by the news. Grant Petrie said: "BSAVA is a not-for-profit registered charity, and Congress is run by vets and nurses. So all of us - organisers, delegates and exhibitors - are supporting the veterinary profession simply by being involved. Together, we are officially part of a record breaking year - with 241 exhibitors in the NIA, along with our fellow associations in the ICC.
"That's more than we've ever had before, and there is a waiting list of companies wanting to join us at this flagship event. So every company who is seriously committed to vets and being involved in supporting the small animal veterinary profession will be with us in the NIA. BSAVA really appreciates the involvement of exhibitors in making Congress such a vital event in the veterinary calendar. It means that not only can we offer remarkably cost-effective CPD, but also provide a showcase of new advances in the industry and the opportunity to get the most from your practice budget. It is where budget holders get the best value, and where exhibitors can meet key decision makers.
"Plus, of course, there's a lot of fun and plenty of free gifts to be found in the NIA too!"
Chanelle has announced the launch of Ketamidor 100 mg/ml Solution for Injection (ketamine), licensed for use in cats, dogs, horses, cattle and swine in the UK and Ireland.
The company says the new product provides a versatile addition to anaesthetic regimes. It can be used in combination with other widely-used anaesthetics and sedatives. Chanelle says it also has analgesic properties that make it particularly beneficial to include in anaesthetic protocols when carrying out painful surgical procedures.
Ketamidor 100mg/ml Solution for Injection has a zero day withdrawal period for milk and meat when used in cattle and pigs, allowing high welfare standards to be maintained without compromising economic returns.
According to Chanelle, ketamine is now experiencing a resurgence of interest as its analgesic properties and minimal impact on spontaneous respiration become increasingly appreciated.1
Angela Wilkin, Chanelle UK's Sales and Marketing Manager said: "Ketamidor makes a great addition to our portfolio of pain management products. Our territory managers are looking forward to speaking to those vets who are already accustomed to using ketamine and those that may be considering adding it to their current protocols."
Reference
During the week, veterinary professionals, retailers and rabbit owners will be encouraged by Burgess and campaign partners the RSPCA, RAWF, Wood Green, PDSA and Blue Cross to sign and share a pledge to move away from muesli on the website: http://www.rabbitawarenessweek.co.uk.
Alex Thorne at Burgess Pet Care, said: "Muesli should never be part of a rabbit’s diet but, sadly, a widespread lack of understanding and awareness around its risks means it’s often too easy for rabbit owners to make the wrong choice. Research continues to show that there is a lack of understanding around the correct nutritional needs of rabbits, and the continued feeding of muesli is a major outcome of that.
"Feeding rabbits muesli increases the risk of selective feeding. Just like children would typically pick sweet treats when faced with the choice between them or vegetables, rabbits will eat parts of the muesli mix that are high in starch and sugar, whilst leaving behind the more nutritious elements.
"We’re encouraging all rabbit lovers to get involved with this year’s campaign by visiting the Rabbit Awareness Week website and signing the ‘Move Away from Muesli’ pledge, before spreading the word amongst fellow rabbit owners. It’s our ambition to move as many rabbits away from muesli towards a good quality hay-based diet supplemented by a small portion of high-quality nuggets and a few fresh greens, which provides the nutrients rabbits need to be happy and healthy."
Burgess says there will also be campaign packs to help support practices in spreading the word, details of which will be available nearer the time.
The charges related to the unexpected death of a cat called Hope during an operation to explore a growth in her mouth, and Dr Dantas-Holmes' subsequent communication with the animal's owners.
Dr Dantas-Holmes accepted that Hope’s death was most likely due to her failing to flush fluid through the giving set attached to an intravenous drip, leaving air in the tubing and causing some air to enter Hope’s bloodstream when the cannula was placed and the giving set’s control opened.
The first set of charges related to Dr Dantas-Holmes’ initial phone call to Hope’s owners ten minutes after Hope’s death, in which she said that Hope had died because of a reaction to anaesthetic drugs. Dr Dantas-Holmes failed to mention that the cause of death was still to be determined and failed to mention that a likely cause was in fact an air embolism and/or a complication relating to the intravenous drip.
Following her initial phone call to the owners Dr Dantas-Holmes viewed CCTV of her actions.
The owners then came into the practice later in the day, and the communications during that time constitute the second set of charges: that, during this meeting, Dr Dantas-Holmes didn’t correct her earlier statements about the cause of Hope’s death, and that she didn’t mention that there was an ongoing investigation or that a likely cause of death was an air embolism and/or complication.
The third set of charges related to Dr Dantas-Holmes’ subsequent clinical records, in which it was alleged that she failed to include references to the findings on review of the CCTV footage of Hope’s death, and the possibility of an air embolism and/or complication relating to the intravenous drip.
The fourth and final set of charges were that her conduct was misleading, and/or dishonest.
With regard to the first set of charges, the Committee found that Dr Dantas-Holmes did tell the owners that Hope died because of a reaction to the drugs, but that given the short nature of the phone call to the owners and the distressing circumstances there was no duty to discuss the investigation, or to mention the likely cause being an air embolism.
Concerning the communications with the owners when they came to the practice, the Committee found that Dr Dantas-Holmes did fail to mention that anaesthetic drugs might not have been the cause, and that she also failed to mention the investigation. Dr Dantas-Holmes had agreed with the Practice Manager, however, that she would not discuss the possibility of an air embolism or complication, and so that charge was not found proved.
On consideration of whether Dr Dantas-Holmes had failed to include relevant findings in the clinical reports, the Committee found both charges proved, and, in relation to the final set of charges, the Committee found that while Dr Dantas-Holmes had misled Hope’s owners, it was unintentional, and she had not been dishonest.
Ultimately, the Committee found Dr Dantas Holmes not guilty of disgraceful conduct in a professional respect.
Stuart Drummond, chairing the Committee and speaking on its behalf, said: "The findings of this Committee demonstrate that there were errors and omissions in communications with the owners. When communicating with a client it is the professional’s responsibility to ensure that the client has heard and understood what has been said. The importance of good and effective communication is particularly important when an unforeseen and shocking event occurs such as it did in this case.
"The particular circumstances of this case demonstrate how important it is to communicate effectively and the need for the veterinary surgeon to ensure that their clinical records for which they are wholly responsible, are complete.
"The Committee concluded that its findings demonstrated a departure from professional standards but that the falling short was not so grave as to amount to disgraceful conduct in a professional respect."
Kruuse has launched the Buster Premium Dog Collar, described as the greatest innovation in Elizabethan dog collars since the original.
The company says the new collar has been designed with two things in mind. First and foremost, patient comfort. Secondly, ease-of-use. Both should help improve compliance.
The new product uses perforated neoprene to provide a snug fit round the neck with no need to attach a separate collar. It's fastened using Velcro, to give a quick but secure fitting. There's padded banding around the inner edge to provides extra comfort and prevent skin irritation, and additional banding around the outer edge to protect the dog's surroundings.
Andrew Groom, Managing Director at Kruuse said: "Worldwide, the Buster collar is the most trusted device to prevent canine patients from biting or licking their body or scratching their head and neck while wounds or injuries heal. The functionality of an e-collar is outstanding when it comes to postoperative care and prevention of self-inflicted trauma.
"The new Buster Premium Collar has been developed in association with vets, vet nurses and dog owners to provide an exceptional collar that is as stress-free as possible for the patient whilst providing exceptional functionality for the user both at the veterinary hospital and at home."
The Premium Buster Collar is available exclusively via NVS: www.vetwholesaler.co.uk
The award, which is sponsored by Zoetis, is for early-career vets who have gone above and beyond the usual call of duty or who are making a difference within their community or the veterinary profession. Fabian was picked out of three finalists at a virtual award ceremony last night.
The judges said he'd wowed them with his ongoing proactive contributions to the veterinary profession and his passion for raising awareness around exotic animal care.
Fabian is a practising vet and the latest member of the team on CBBC children’s TV show, ‘The Pets Factor’. He is also a recent graduate member of BVA Council.
In his spare time, he is an active writer. Whilst attending the University of Veterinary and Pharmaceutical Sciences in Brno, which he graduated from in 2018, he wrote his own student blog, ‘Dready Vet’. Since then, he has published several articles on a variety of topical and important issues such as ethnicity and race, diversity within the profession, feminism, Halal slaughter and reptile health and welfare.
The judges credited Fabian for his passion for communicating the complex welfare needs of non-traditional companion animals to the public.
Fabian said: "First of all I’d like to pay tribute to Nat and Ben and all the nominees. They are really important to where the veterinary profession goes in the future and I’m indebted to them for what they’ve been able to do in a short period of time. They are an inspiration to me.
"Thank you to the judges. It’s really important that we start to celebrate each other and celebrate our wins. This is something I’ve tried hard to do this year.
"Thank you to everyone who’s supported me and been part of this journey. It means a huge amount.”
BVA President James Russell said: "Fabian has made a significant impact within the profession and beyond. The broad reach of his work – on issues that affect our profession and animal welfare – has made a national impact and promoted our profession to new audiences of all ages.
"During a particularly challenging year for all of us, Fabian has shown immense leadership and he is a truly deserving winner of the BVA Young Vet Award 2020."
Alstoe is launching Vetergesic Multidose, a 10ml version of the opiate injection, in a new multi-use vial.
Alstoe Technical Director, Dr Ian Ryder said: "In addition to the new vial size the inclusion of a preservative enables Vetergesic Multidose to be used for up to 28 days following its initial use. Also the product is now licensed for intravenous administration."
Vetergesic Multidose should drastically reduce the amount of product wasted by practices using the old, smaller single-use vial.
Alstoe says that supplying Vetergesic in a multi-use vial was one of the first things discussed with the drug originators, Reckitt Benckiser, when it took over the marketing of the product. However, for a large scale medical pharmaceutical manufacturer to consider producing a veterinary product in a different pack and in much smaller production runs than their medical operating scales, the answer is normally no. But in this case, Reckitts gave the project its full support, so in addition to reduced wastage, the inconvenience of snapping glass necks will become a thing of the past.
Please contact Alstoe Ltd for further information at info@alstoe.co.uk or telephone 01347 878606.
It's the second of five new practices that White Cross says it plans to open in a 12-month period.
The Hyde team will be headed up by clinic director Mike Robinson MRCVS, pictured with veterinary nurses Anneliese O'Toole & Aimee Lee.
Located on the site of a former pub, the new Hyde practice opened this month following an investment of £250,000. It is equipped with digital dental x-ray and ultrasound machines, an on-site laboratory, pheromone diffusers to relax pets, ultra-soft bedding and warm, cosy LED lighting in the pet wards.
There are separate, sound-proofed wards for dogs and a specialist cat ward featuring kennels positioned so the cats can’t see each other, to minimise stress-levels. Music specifically composed to reduce anxiety in both dogs and cats is also played in the wards.
Tim Harrison, managing director at White Cross Vets, said: "Hyde is a busy suburb of Manchester with a large number of pets in the surrounding area, which made it the ideal location to continue our expansion into the North West.
"Mike and the team are all highly experienced professionals and bring lots of enthusiasm to their new roles. When this is combined with the practice’s state of the art design, there’s no doubt it will prove to be hugely popular.
"It also offers the potential to expand the team to approximately 20 people in the next five years, which is an exciting prospect."
The main changes announced today are:
In the future, the revalidation interval, which currently ranges from two to five years depending on the course, will be standardised at 4 years.
Currently, there is a two-month window in which Official Veterinarians (OV) can submit their final declarations, on completion of the course, if they want to set their next revalidation interval from the end of the window.
The revalidation window will be extended to a six-month period prior to the completion deadline date. If completed in this window, the date of the next revalidation would be taken from the deadline date and not the date of completion.
APHA is discussing ways of making invigilation more flexible, to help those working in sole-charge or remote practices. One option being investigated with course accreditation providers is remote invigilation, though this would come at extra cost.
All the multiple choice questions in the online exams are being reviewed to make sure they test the ability to perform the role, and in the future, candidates will be given more feedback at the end of the test (ie which questions they answered incorrectly).
In terms of CPD requirements, there will be clarification on what can be considered relevant CPD towards the 10 hours that need to be completed over the four-year timeframe.
Lastly, APHA has announced a raft of changes concerning course content, and that it will itself review all the courses to consider how the number of courses and topics can be rationalised, how to reduce the number of qualifications any OV might need and/or the time spent revalidating, and how to reduce the content without losing quality.
The BVA, which spearheaded the campaign for reform, has welcomed the announcement. Simon Doherty, BVA President, said: "We’re delighted that APHA has taken on board our members’ concerns with the current system and proposed improvements that should make the process much more fair and consistent while continuing to maintain high standards. This is a really crucial time for ensuring that the workforce retains skilled professionals and is at full strength to keep animal welfare standards high, protect public health and meet demand for export certification after Brexit.
"This piece of work is a shining example of what can be achieved when vets pull together to air concerns and make the case for change. We will continue to work closely with APHA to explore and put in place ways of making the revalidation process as fit for purpose as possible for this critical section of the workforce."
Full review: http://apha.defra.gov.uk/documents/ov/Briefing-Note-0519.pdf
Whilst you're here, take a moment to see our latest job opportunities for vets.
The drug monographs for both formularies were revised and updated by the editorial panels in 2022, so the new edition contains the most up-to-date information about the medications used for dogs, cats and exotic pets.
The new formularies contain new drugs, new drug monographs, updated antimicrobial guidelines, parasiticide guidelines and sedation protocols.
The new formularies are available to buy at the BSAVA Publications stand at Congress, with a special 20% Congress discount.
Eligible members who are attending Congress can collect their copy of the BSAVA Small Animal Formulary, 11th edition – Part A: Canine and Feline from the Exhibition Hall.
Any eligible members who are not going to BSAVA Congress will be sent their printed copy from April 2023 onwards.
Eligible members will be sent their printed copy of the BSAVA Small Animal Formulary, 11th edition – Part B: Exotic Pets from April 2023 onwards.
All BSAVA members have access to the online version via the BSAVA Library and the BSAVA app.
Both Part A and Part B are available in print from www.bsava.com/shop (£55; £35.75 to BSAVA members), or as part of a 12-month digital subscription from www.bsavalibrary.com/formulary with Part A: Canine and Feline, Part B: Exotic Pets and the client information leaflets (£256 + VAT; free to BSAVA members).
Virbac says Michelle is widely recognised as one of the world’s leading experts in companion animal reproductive biology.
She graduated from Washington State University College of Veterinary Medicine, before completing a residency at Cornell University and becoming board-certified in Theriogenology.
She earned a PhD in physiology at Cornell University and is currently a Full Professor at Oregon State University.
Michelle is also a member of the WSAVA Reproduction Control Committee which recently previewed its new Global Guidelines for Reproduction Control during WSAVA Congress in September.
Dr Neil Mottram MRCVS, Technical Manager at Virbac said: "The UK has the highest rate of surgical castration in Europe, but with new WSAVA global reproduction control guidelines expected to be published imminently, increasing evidence on the effect of surgical castration on long-term health and even the UK’s leading animal welfare charities updating their guidance on neutering dogs, there’s no better time to review practice neutering policies.
"In line with an evidence-based approach, we want to pose the question: is surgical castration right for every dog?"
www.bit.ly/caninecastration
Hot on the heels of Eurovet, Ceva Animal Health has launched Emeprid, containing the anti-emetic and pro-kinetic metoclopramide. Emeprid is licensed in cats and dogs for the symptomatic treatment of vomiting and reduced gastro-intestinal motility associated with gastritis, pyloric spasm, chronic nephritis and digestive intolerance to some drugs.
There are two formulations available; a 10ml multi-dose vial containing 5mg/ml metoclopramide for IV, SC or IM injection and a 125ml 'sweet orange and apricot flavoured' oral solution containing 1mg/ml metoclopramide. They are priced at £7.99 for the 10ml injectable bottle and £9.99 for the oral solution.
For further information, please contact your Ceva Animal Health representative or call the veterinary support team on 01494 781510.
Dr Bremner was convicted in 2017 of harassing his ex-wife, and for perverting the course of justice by sending his daughter an e-mail, pressuring her to ask her mother to withdraw the charges against him. He pleaded guilty to both of the charges, saying he did not understand that it was a condition of his bail that he could not contact his ex-wife. He also expressed shame and remorse at his actions, explaining that his behaviour was triggered by extreme anger, grief and stress.
In relation to the charges, the Respondent was committed to prison for 12 months, suspended for 12 months, ordered to comply with a Rehabilitation Activity Requirement within 12 months, and ordered to pay £85 in costs and £115 as a surcharge to pay for victim services.
The Committee found the facts proved based on the certified copy of the certificate of conviction, as well as the Respondent’s admissions to the facts of the charges. It was satisfied that the Respondent brought the profession into disrepute by the seriousness of his convictions. In addition, the Committee regarded the Respondent as having deficient insight and a need to fully accept personal responsibility for his actions and their consequences.
The Committee was also satisfied that the nature of the communications sent by the Respondent which led to the convictions and the breach of bail conditions, coupled with deficient insight amounted to serious professional misconduct and rendered him unfit to practise veterinary surgery.
The Committee considered various mitigating factors including the fact that no actual harm occurred to any animal, there were no concerns raised about the respondent’s practice, that he has a long and unblemished career, and that he showed some insight into his offences which continues to develop.
The Committee also took into account that preventing the Respondent from practicing could mean the loss of jobs for 33 or so employees, which weighed heavily on their decision. The Committee also agreed with the RCVS’s submissions that there was a very low likelihood of repetition of the offending behaviour. Aggravating factors included the emotional harm caused to the Respondent’s ex-wife, and that the harassment was a course of conduct sustained over a period of five months.
Therefore, when taking into account the particulars of this case, the Committee decided to impose a reprimand and warning on the basis that it would be proportionate to maintain public confidence in the profession in light of the serious nature of these charges.
Chitra Karve, chairing the Committee and speaking on its behalf, said: "The Committee was of the view that the conviction for intending to interfere with the course of justice was particularly serious, in light of the need to maintain public confidence in the profession, because it involved a disregard of proper criminal process.
"However, a particular feature of this case is the risk to the jobs of 33 or so employees if the Respondent were to be prevented from practising as a result of the Committee’s imposition of a sanction. It is this mitigating factor which weighed most heavily with the committee and they therefore concluded that both a Reprimand as to this conduct and a Warning as to any future conduct is sufficient and proportionate in this case to meet the need to maintain public confidence in the profession and uphold proper standards."
Mr Bremner has 28 days in which to make an appeal about the Committee’s decision to the Privy Council.
Sam Joseph, co-founder of StreetVet said: "It is especially important for the dogs belonging to the homeless and vulnerably housed to be microchipped and not just because it is now a legal requirement, a registered microchip is often the only way for them to provide evidence of keepership."
We are so grateful to Animalcare for providing StreetVet with identichip microchips as we are now able to ensure that all the dogs that we treat are chipped and registered to their owners. Animalcare will also allow free, life-long change of address for microchips implanted by StreetVet meaning the homeless owners can easily change the registration details if they are able to find accommodation or if they move again in the future. This amazing support will give real peace of mind to the owners of the dogs we treat."
James Beaumont from Animalcare Ltd: "Animalcare provides the UK’s most advanced pet microchipping service through identichip, which has led the way for nearly 30 years. I’m pleased that Animalcare can support such a worthy cause, and hope this is the start of a long relationship with StreetVet."
Photo: Jade Statt of StreetVet and James Beaumont of Animalcare Ltd at BSAVA Congress.
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
On Tuesday 8th September Dr Owen Davies, an RCVS and American Specialist in Veterinary Oncology, will present ‘Mast Cell Tumours: An Update’, in which he will review mast cell tumours and diagnostic approaches before appraising the current treatment options.
On Wednesday 9th September Dr Pam Jones, a double board certified Specialist in Veterinary Medical Oncology and Radiation Oncology from the US, will present ‘Stelfonta: Seeing is Believing’.
Dr Jones will introduce delegates to the unique mode of action of tigilanol tiglate, review the efficacy data behind the new product and demonstrate how this treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.
Dr Neil Mottram, Technical Product Manager at Virbac said: “The effects of Stelfonta really do need to be seen to be believed, so we’re excited to offer vets the opportunity to learn more about this ground-breaking advancement in veterinary oncology. We are lucky to have secured some fantastic speakers for the webinars so delegates can be assured of some top quality CPD.”
Both events will be hosted by The Webinar Vet and begin at 7:30pm. Registration for the event is now open and can be found at www.thewebinarvet.com/stelfonta
For more information, speak to your Virbac Territory Manager or visit vet-uk.virbac.com/stelfonta
The Davies Therapy and Fitness Centre has been developed following two years of planning with the intention of supporting referring practices.
Run by a team of Chartered Veterinary Physiotherapists, hydrotherapists and anaesthetists, it has a large hydrotherapy suite, a therapeutic exercise area and gym, an outdoor exercise area, four spacious consultation and treatment rooms and a bright and airy reception.
Services include physiotherapy, rehabilitation, underwater treadmill therapy, soft supports, splinting and orthotics, fitness and conditioning and acupuncture and pain management clinics.
Good rehabilitation is pivotal to the recovery process following injury or surgery and for the management of long-term conditions such as arthritis. DVS says owners are more likely to be compliant with veterinary rehabilitation and fitness programmes if they can fully understand the importance of the process by working with a friendly, professional team, preferably at a bespoke centre.
Diane Messum, Head of Physiotherapy said: "Our mission is to work with referring practitioners to treat every pet, and their owner, with the utmost care and compassion throughout the entire veterinary process. We aim to minimise pain and restore the animals we treat to their maximum physical and mental wellbeing, with the provision of expert therapy, fitness and pain management."
To find out more visit www.vetspecialiststherapy.co.uk